Clinicopathologic and Molecular Characteristics of HER2 (ERBB2)-Altered Non–Small Cell Lung Cancer: Implications for Precision Medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinicopathologic and Molecular Characteristics of HER2 (ERBB2)-Altered Non–Small Cell Lung Cancer: Implications for Precision Medicine

Published:2024-06 Issue:6 Volume:37 Page:100490
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Lee Yurimi^ORCID,Lee Boram^ORCID,Choi Yoon-La^ORCID,Kang Dong-Wook,Han Joungho

Publisher

Elsevier BV

Reference47 articles.

1. Targeting HER2 in the treatment of non-small cell lung cancer;Mar;Lung Cancer,2015

2. Molecular landscape of ERBB2 alterations in 14,956 solid tumors;Wang;Pathol Oncol Res,2022

3. Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung;Grob;Mod Pathol,2012

4. A review of HER2 overexpression and somatic mutations in cancers;Galogre;Crit Rev Oncol Hematol,2023

5. Clinical characteristics and outcomes of non-small cell lung cancer patients with HER2 alterations in Korea;Lee;Cancer Res Treat,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Chest CT Imaging Feature Model in Distinguishing Squamous Cell Carcinoma and Adenocarcinoma of the Lung;Cancer Management and Research;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP